By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Discovery and development of biopharmaceutical products3.2K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States3.2K100.00%